8176 (8176) Fair Value & Analysis

Consumer Defensive · Market cap HK$17.2M

8 8176 8176 · HK

PriceHK$0.0240

Fair ValueHK$0.0273

Upside+13.8%

Quality26/100

Watch 8176 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.0251 – HK$0.0296

Fair value as of: Jul 3, 2026

From 6 valuation models · updated today

Price vs Fair Value (12 months)

12‑month range HK$0.0170 – HK$0.1590 · fair‑value band HK$0.0251 – HK$0.0296 · the HK$0.0240 price screens below the HK$0.0273 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8176 (8176) currently trades at HK$0.0240, while our model-based Fair Value estimate is HK$0.0273 — implying the stock looks roughly 13.8% undervalued today. We read business quality at 26/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 8176 generated revenue of HK$29.6M at a net margin of -39.2%. Revenue declined 9.1% year over year. Net debt stands at HK$154M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) HK$29.6M

Revenue growth (YoY) -9.1%

Net margin -39.2%

Free cash flow −HK$9.3M FY2025

Operating margin 40.6%

EPS (TTM) HK$-0.0100

More key figures

EPS growth (YoY) -86.0%

Net debt HK$154M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

8176 reported revenue of HK$29.6M in FY2025 versus HK$18.5M in FY2021, a compound +12.6%/yr. Reported net income was −HK$11.6M in FY2025.

Revenue +12.6%/yr

FY21 HK$18.5M

FY22 HK$4.0M

FY23 HK$15.1M

FY24 HK$29.9M

FY25 HK$29.6M

Net income

FY21 −HK$36.9M

FY22 −HK$13.7M

FY23 −HK$27.8M

FY24 −HK$10.2M

FY25 −HK$11.6M

Is 8176 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock	Price	Fair Value	vs Fair Value
PG PG	2,590 MXN	1,415 MXN	-45%
The Procter & Gamble Company PGCO34	R$53.60	R$29.97	-44%
L'Oréal S.A LRLCF	$428.02	$273.79	-36%
Unilever PLC UNLYF	$59.34	$46.11	-22%
Colgate-Palmolive Company CPA	€79.16	€55.96	-29%
Hindustan Unilever Limited HINDUNILVR	₹2,185	₹1,000	-54%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8176 (8176) undervalued?

As of Jul 3, 2026, our model estimates a fair value of HK$0.0273 versus a price of HK$0.0240 — about +14% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 8176?

Our model-based fair value for 8176 is HK$0.0273 (as of Jul 3, 2026), built from audited fundamentals. The current price is HK$0.0240.

What is the quality score of 8176?

8176 has a Quality Score of 26/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8176 (8176)?

8176 reported trailing-twelve-month revenue of about HK$29.6M (latest available figure, as of Jul 3, 2026).

What is the net profit margin of 8176?

The net profit margin of 8176 is about -39.2%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.